Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 2/20 | 0.32 |
| ▸ | CRHBP | P24387 | 1/20 | 0.32 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21302915 | 1.00 | ALDH1A1 (0.36) | ALDH1A1MAOACYP1A2AHRCRHBP | |
| SCHEMBL21983246 | 0.94 | ALDH1A1 (0.41) | ALDH1A1MAOACYP1A2CRHBPCRHR2 | |
| SCHEMBL21982992 | 0.92 | CYP1A2 (0.41) | ALDH1A1CYP1A2CRHBPCRHR2EGFR | |
| SCHEMBL21983181 | 0.92 | AHR (0.31) | AHR | |
| SCHEMBL24677329 | 0.92 | AHR (0.33) | MAOAAHRALOX5MAOB | |
| SCHEMBL21793762 | 0.85 | ALDH1A1 (0.33) | ALDH1A1CYP1A2AHRCRHBPCRHR2 | |
| SCHEMBL20908597 | 0.84 | FAAH (0.33) | ALDH1A1MGLL | |
| SCHEMBL19938322 | 0.84 | FAAH (0.33) | ALDH1A1MGLL | |
| SCHEMBL21414507 | 0.84 | KMO (0.33) | ALDH1A1MAOAEGFRMGLLCA12 | |
| SCHEMBL16889443 | 0.84 | KMO (0.33) | ALDH1A1MAOAEGFRMGLLCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337525-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-10651395-B2 | Organic electroluminescent element, display device, and illumination device | Konica Minolta, Inc. (JP) | 2020-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337525-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OXER1 | ALDH1A1 60/4885MAOA 380/4885CYP1A2 257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.